Lifecore Biomedical Inc (LFCR)
5.77
-0.22
(-3.67%)
USD |
NASDAQ |
May 16, 16:00
5.78
+0.01
(+0.17%)
After-Hours: 20:00
Lifecore Biomedical Max Drawdown (5Y): 89.19% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 89.19% |
| March 31, 2024 | 89.19% |
| February 29, 2024 | 89.19% |
| January 31, 2024 | 89.19% |
| December 31, 2023 | 89.19% |
| November 30, 2023 | 89.19% |
| October 31, 2023 | 89.19% |
| September 30, 2023 | 89.19% |
| August 31, 2023 | 89.19% |
| July 31, 2023 | 89.19% |
| June 30, 2023 | 89.19% |
| May 31, 2023 | 89.19% |
| April 30, 2023 | 89.19% |
| March 31, 2023 | 89.19% |
| February 28, 2023 | 62.72% |
| January 31, 2023 | 60.71% |
| December 31, 2022 | 58.06% |
| November 30, 2022 | 50.87% |
| October 31, 2022 | 50.87% |
| September 30, 2022 | 50.87% |
| August 31, 2022 | 50.87% |
| July 31, 2022 | 50.87% |
| June 30, 2022 | 50.87% |
| May 31, 2022 | 50.87% |
| April 30, 2022 | 50.87% |
| Date | Value |
|---|---|
| March 31, 2022 | 50.87% |
| February 28, 2022 | 50.87% |
| January 31, 2022 | 50.87% |
| December 31, 2021 | 50.87% |
| November 30, 2021 | 50.87% |
| October 31, 2021 | 50.87% |
| September 30, 2021 | 50.87% |
| August 31, 2021 | 50.87% |
| July 31, 2021 | 50.87% |
| June 30, 2021 | 50.87% |
| May 31, 2021 | 50.87% |
| April 30, 2021 | 50.87% |
| March 31, 2021 | 50.87% |
| February 28, 2021 | 50.87% |
| January 31, 2021 | 50.87% |
| December 31, 2020 | 50.87% |
| November 30, 2020 | 50.87% |
| October 31, 2020 | 50.87% |
| September 30, 2020 | 50.87% |
| August 31, 2020 | 50.87% |
| July 31, 2020 | 50.87% |
| June 30, 2020 | 50.23% |
| May 31, 2020 | 50.23% |
| April 30, 2020 | 50.23% |
| March 31, 2020 | 50.23% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
39.48%
Minimum
May 2019
89.19%
Maximum
Mar 2023
58.51%
Average
50.87%
Median
Jul 2020
Max Drawdown (5Y) Benchmarks
| Aquestive Therapeutics Inc | 96.68% |
| SELLAS Life Sciences Group Inc | 100.00% |
| ADMA Biologics Inc | 84.77% |
| Relmada Therapeutics Inc | 95.67% |
| Jaguar Health Inc | 100.00% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -22.31 |
| Beta (5Y) | 0.9754 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 65.70% |
| Historical Sharpe Ratio (5Y) | -0.1741 |
| Historical Sortino (5Y) | -0.3475 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.85% |